alpha-v integrin antisense inhibitor (AVI BioPharma)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-v integrin antisense inhibitor (AVI BioPharma)
Drug Alias Namealpha-v integrin phosphorodiamidate morpholino oligomer (AVI BioPharma)alpha-v integrin PMO (AVI BioPharma)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionIntegrin alpha-V modulators
TargetsIntegrin alpha-V
Therapy Area/IndicationsAngiogenesis disorderRetinal DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarepta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderRetinal DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A